Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 23, 2025
Three-dimensional preclinical models for Osteosarcoma: Advances and translational prospectsAurora Puce, Virginia Ferraresi, Roberto Biagini, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 3, 2016
Epitelial-to-mesenchimal transition and invasion are upmodulated by tumor-expressed granzyme B and inhibited by docosahexaenoic acid in human colorectal cancer cellsDonatella D'Eliseo, Giuliana Di Rocco, Rossella Loria, et al.
JHLT Open|February 18, 2026
MicroRNAs and their role in heart transplantation insights into rejection mechanisms: A narrative reviewRossella Loria, Antonio Giuseppe Bianculli, Paola Giustiniani, et al.
Frontiers in Oncology|July 11, 2022
Cross-Resistance Among Sequential Cancer Therapeutics: An Emerging IssueRossella Loria, Patrizia Vici, Francesca Sofia Di Lisa, et al.
Frontiers in Oncology|November 17, 2022
Corrigendum: Cross-resistance among sequential cancer therapeutics: An emerging issueRossella Loria, Patrizia Vici, Francesca Sofia Di Lisa, et al.
Oncotarget|December 16, 2016
Prognostic role of NF-YA splicing isoforms and Lamin A status in low grade endometrial cancerLucia Cicchillitti, Giacomo Corrado, Mariantonia Carosi, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 5, 2019
Very low intensity ultrasounds as a new strategy to improve selective delivery of nanoparticles-complexes in cancer cellsRossella Loria, Claudia Giliberti, Angelico Bedini, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 8, 2018
Endometrial cancer prognosis correlates with the expression of L1CAM and miR34a biomarkersGiacomo Corrado, Valentina Laquintana, Rossella Loria, et al.
Surgical Oncology|March 11, 2019
The prognostic significance of positive peritoneal cytology in endometrial cancer and its correlations with L1-CAM biomarkerEnrico Vizza, Emanuela Mancini, Valentina Laquintana, et al.
Oncotarget|January 11, 2015
Sema6A and Mical1 control cell growth and survival of BRAFV600E human melanoma cellsRossella Loria, Giulia Bon, Valentina Perotti, et al.
Pageof 2